Search ARM

AffyXell Therapeutics Co., Ltd. is developing a novel cell & gene therapy based on mesenchymal stem cell (MSC) to obstacle the diseases that come from an imbalance of immune system homeostasis. Immunomodulation function by MSC is further increased with the Affimer® platform, restoring immunologic balance, and we will do the best we can to lead in treating diseases with a new therapeutic approach that can resolve fundamental causes of intractable diseases like immune rejection and autoimmune diseases.
Contact AffyXell Therapeutics
Visit Website